Circadian effects of dopaminergic treatment in restless legs syndrome
- 31 July 2004
- journal article
- clinical trial
- Published by Elsevier BV in Sleep Medicine
- Vol. 5 (4), 413-420
- https://doi.org/10.1016/j.sleep.2004.01.007
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Circadian Clues to Sleep Onset MechanismsNeuropsychopharmacology, 2001
- Cerebrospinal Fluid and Plasma Leptin Measurements: Covariability with Dopamine and Cortisol in Fasting HumansJournal of Clinical Endocrinology & Metabolism, 1999
- Relationship between Napping and Melatonin in the BlindJournal of Biological Rhythms, 1997
- Melatonin increases the in situ activity of tyrosine hydroxylase in the mediobasal hypothalamus of male syrian hamstersLife Sciences, 1996
- Daytime melatonin administration enhances sleepiness and theta/alpha activity in the waking EEGNeuroscience Letters, 1996
- Toward a better definition of the restless legs syndromeMovement Disorders, 1995
- Circadian Variations of Urinary Dopamine, Norepinephrine, Epinephrine and Sodium in Normotensive and Hypertensive SubjectsNephron, 1990
- Dopamine release induced by electrical field stimulation of rat hypothalamus invitro: Inhibition by melatoninBiochemical and Biophysical Research Communications, 1982
- The circadian variation in dopamine metabolism in the subhuman primateJournal of Neurochemistry, 1977
- The Biochemical Basis of NeuropharmacologyAnesthesiology, 1975